CompletedNot Applicable

Medical and Surgical Hybrid Treatment of Atrial Fibrillation.

France12 participantsStarted 2015-09

Plain-language summary

The objective of the study is to investigate the feasibility of a hybrid procedure removal of the atrial fibrillation. This is a single procedure for both surgical epicardial by minimally invasive route (Thoracoscopy) without even flow controlled and supplemented if necessary by extra corporeal intracavitary route at the same time. This faster procedure combined with complete lesions have a higher success rate and less frequent re-hospitalizations of patients.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: patients with complex AF defined by the following criteria : * AF\> 1 week or long term persistent\> 1 year * AND Symptomatic * AND after failure of treatment of anti-arrhythmic or against-indication for anti-arrhythmic Exclusion Criteria: The exclusion criteria are relevant contraindications thoracoscopy or the non-complex nature of the AF: * Paroxysmal AF or AF cardioverted anti-arrhythmic test (unless against indicated) * Recent AF for which a simple gesture is intracavitary considered sufficient * Permanent AF * Asymptomatic AF * Very old AF (\> 5 years) or atrial major ectasia (\> 60 mm) * Need another surgery (valve bypass coronary) * Previous history of sternotomy or thoracotomy * High-risk surgical or anesthetic Patient * BMI\> 35 * Sleep Apnea * Ejection fraction \<35% * Thoracic trauma history * Veins Pulmonary stenosis\> 50% * Hyperthyroidism * Thrombus in LAA

What they're measuring

Number of participants with complete procedure or not

Timeframe: 3 hours

Trial details

NCT IDNCT02630914

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03